Table 2 Univariate analysis of the association between CAR-H and 5-year outcomes

CAR-H

1.815 (1.280–2.574)

<0.001

2.085 (1.321–3.291)

0.002

Age

1.060 (1.041–1.080)

<0.001

1.058 (1.032–1.084)

<0.001

Men

1.187 (0.780–1.806)

0.424

1.231 (0.708–2.141)

0.461

Body mass index

1.005 (0.951–1.063)

0.848

1.039 (0.967–1.116)

0.295

Previous PCI

1.599 (1.113–2.298)

0.011

1.892 (1.190–3.010)

0.007

Previous CABG

0.990 (0.436–2.248)

0.981

0.833 (0.263–2.646)

0.757

Hypertension

1.530 (1.005–2.328)

0.047

1.583 (0.910–2.753)

0.104

COPD

4.426 (2.384–8.216)

<0.001

5.581 (2.679–11.630)

<0.001

PVD

1.464 (0.683–3.139)

0.327

1.428 (0.521–3.911)

0.488

Previous Stroke

1.478 (0.940–2.322)

0.090

1.411 (0.775–2.568)

0.260

Previous MI

1.619 (1.100–2.383)

0.015

2.465 (1.541–3.944)

<0.001

Current/ever-smoker

1.279 (0.893–1.833)

0.180

1.744 (1.066–2.854)

0.027

ACS

0.830 (0.585–1.177)

0.296

1.020 (0.644–1.616)

0.932

Haemoglobin

0.985 (0.974–0.996)

0.008

0.979 (0.965–0.993)

0.004

White blood cell count

1.062 (0.977–1.156)

0.159

1.074 (0.964–1.196)

0.198

eGFR

0.970 (0.961–0.979)

<0.001

0.962 (0.951–0.972)

<0.001

Glucose

1.047 (0.985–1.112)

0.140

1.056 (0.978–1.141)

0.164

SYNTAX Score

1.000 (0.980–1.022)

0.968

0.995 (0.967–1.023)

0.705

GPI

0.870 (0.528–1.432)

0.584

0.723 (0.360–1.451)

0.361

Clopidogrel

NA

NA

NA

NA

Statin

1.102 (0.451–2.696)

0.831

1.642 (0.403–6.691)

0.489

Beta-blocker

0.856 (0.472–1.552)

0.609

0.652 (0.325–1.309)

0.229